Pectin from Okra (Abelmoschus esculentus L.) Has Potential as a Drug Release Modifier in Matrix Tablets

Simple item page
dc.contributor.authorEl Boakye-Gyasi, Mariam
dc.contributor.authorOwusu, Frederick William Akuffo
dc.contributor.authorEntsie, Philomena
dc.contributor.authorAgbenorhevi, Jacob K.
dc.contributor.authorBanful, Ben Kwaku Branoh
dc.contributor.authorBayor, Marcel Tunkumgnen
dc.contributor.orcid0000-0002-8879-230X
dc.contributor.orcid0000-0003-2674-6217
dc.contributor.orcid0000-0002-4858-8339
dc.contributor.orcid0000-0002-8516-7656
dc.contributor.orcid0000-0003-2268-6122
dc.contributor.orcid0000-0002-4170-1140
dc.date.accessioned2024-02-16T12:33:06Z
dc.date.available2024-02-16T12:33:06Z
dc.date.issued2021
dc.descriptionThis article is published in The Scientific World Journal Volume 2021, Article ID 6672277, 10 pages; https://doi.org/10.1155/2021/6672277
dc.description.abstractNatural polymers have become attractive to pharmaceutical researchers and manufacturers as excipients because of the ad vantages they possess relative to their semisynthetic and synthetic counterparts. Although pectin from some natural sources has been investigated for use in the pharmaceutical industry as excipients, pectin from okra, which is readily available and used as food in many parts of the world, has not been extensively investigated as a potential control-releasing agent in tablets. ,is study thus seeks to determine the drug release modifying properties of okra pectin from 6 different genotypes of okra cultivated and available in Ghana. Pectin was extracted from different genotypes of okra, physicochemical properties were characterized, and control release matrix tablets of metformin (F1–F6) were formulated using the wet granulation method with the okra pectin as the drug release modifier, respectively. ,e drug content, in vitro drug release, and mathematical kinetic modeling of drug release from the matrix tablets were studied. Drug release profiles of formulated matrix tablets were compared to an existing (innovator) brand of metformin sustained-release tablet on the market using the similarity and difference factors, respectively. ,e extracted pectin had percentage yields ranging from 6 to 20% w/w with swelling indexes and water-holding capacities between 300–500% and 9-10 mL/ g, respectively, and pH within 6.20–6.90. All the formulated batches passed the drug content test (90–105%) and produced the optimal release of metformin (>80%) after 24 hours. Different batches of formulated tablets exhibited different mechanisms of drug release with batches F1, F2, F5, and F6 being similar (f 2 values being >50 and f 1 values <15) to the innovator brand. Pectin from the 6 different genotypes of okra studied has the potential for use as drug release modifiers in pharmaceutical manufacturing of control release matrix tablets and production of more affordable medicines.
dc.description.sponsorshipKNUST
dc.identifier.citationThe Scientific World Journal Volume 2021, Article ID 6672277, 10 pages; https://doi.org/10.1155/2021/6672277
dc.identifier.urihttps://doi.org/10.1155/2021/6672277
dc.identifier.urihttps://ir.knust.edu.gh/handle/123456789/15489
dc.language.isoen
dc.publisherThe Scientific World Journal
dc.titlePectin from Okra (Abelmoschus esculentus L.) Has Potential as a Drug Release Modifier in Matrix Tablets
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
6672277.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles